Core promoter mutations of hepatitis B virus for the response to interferon in E antigen-positive chronic hepatitis B

American Journal of Gastroenterology

Volumn 91, Issue 10, 1996, Pages 2150-2156

  Kanai, Koichi ^b   Kako, Makoto ^b   Aikawa, Tatsuya ^b   Hino, Kunihiko ^b   Tsubouchi, Hirohito ^b   Takehira, Yasunori ^b   Iwabuchi, Shogo ^b   Kawasaki, Tsunehisa ^b   Tsuda, Fumio ^b   Okamoto, Hiroaki ^b   Miyakawa, Yuzo ^b   Mayumi, Makoto ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B(E) ANTIGEN; INTERFERON; RECOMBINANT ALPHA2A INTERFERON; VIRUS DNA;

ADULT; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOTHERAPY; MALE; POINT MUTATION; PRIORITY JOURNAL; PROGNOSIS; VIRUS MUTATION;

ADULT; ANTIVIRAL AGENTS; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B CORE ANTIGENS; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS, CHRONIC; HUMANS; INTERFERON ALFA-2A; MALE; POINT MUTATION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROMOTER REGIONS (GENETICS);

EID: 0029819329     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Realdi G, Alberti A, Rugge M, et al. Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection. Gastroenterology 1980;79:195-9.
2. Hoofnagle JH, Dusheiko GM, Seeff LB, et al. Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis. Ann Intern Med 1981;94:744-8.
3. Tine F, Liberati A, Craxi A, et al. Interferon treatment in patients with chronic hepatitis B: A meta-analysis of the published literature. J Hepatol 1993;18:154-62.
4. Ryff JC. To treat or not to treat? The judicious use of interferon-alpha-2a for the treatment of chronic hepatitis B. J Hepatol 1993;17: S42-6.
5. Wong DK, Cheung AM, O'Rourke K, et al. Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B: A meta-analysis. Ann Intern Med 1993;119:312-23.
6. Bruss V, Gerlich WH. Formation of transmembraneous hepatitis B e-antigen by cotranslational in vitro processing of the viral precore protein. Virology 1988;163:268-75.
7. Garcia PD, Ou JH, Rutter WJ, et al. Targeting of the hepatitis B virus precore protein to the endoplasmic reticulum membrane: After signal peptide cleavage translocation can be aborted and the product released into the cytoplasm. J Cell Biol 1988;106:1093-104.
8. Carman WF, Jacyna MR, Hadziyannis S, et al. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet 1989;2:588-91.
9. Okamoto H, Yotsumoto S, Akahane Y, et al. Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen. J Virol 1990;64: 1298-303.
10. Takeda K, Akahane Y, Suzuki H, et al. Defects in the precore region of the HBV genome in patients with chronic hepatitis B after sustained seroconversion from HBeAg to anti-HBe induced spontaneously or with interferon therapy. Hepatology 1990;12:1284-9.
11. Naoumov NV, Schneider R, Grotzinger T, et al. Precore mutant hepatitis B virus infection and liver disease. Gastroenterology 1992;102: 538-43.
12. Xu J, Brown D, Harrison T, et al. Absence of hepatitis B virus precore mutants in patients with chronic hepatitis B responding to interferon-alpha. Hepatology 1992;15:1002-6.
13. Loriot MA, Marcellin P, Talbodec N, et al. Low frequency of precore hepatitis B virus mutants in anti-hepatitis B e-positive reactivation after loss of hepatitis B e antigen in patients with chronic hepatitis B. Hepatology 1995;21:627-31.
14. Lok ASF, Akarca US, Greene S. Predictive value of precore hepatitis B virus mutations in spontaneous and interferon-induced hepatitis B e antigen clearance. Hepatology 1995;21:19-24.
15. Yaginuma K, Shirakata Y, Kobayashi M, et al. Hepatitis B virus (HBV) particles are produced in a cell culture system by transient expression of transfected HBV DNA. Proc Natl Acad Sci USA 1987; 84:2678-82.
16. Yuh CH, Chang YL, Ting LP. Transcriptional regulation of precore and pregenomic RNAs of hepatitis B virus. J Virol 1992;66:4073-84.
17. Okamoto H, Tsuda F, Akahane Y, et al. Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen. J Virol 1994;68:8102-10.
18. Sato S, Suzuki K, Akahane Y, et al. Hepatitis B virus strains with mutations in the core promoter in patients with fulminant hepatitis. Ann Intern Med 1995;122:241-8.
19. De Groote J, Desmet VJ, Gedigk P, et al. A classification of chronic hepatitis. Lancet 1968;2:626-8.
20. Aikawa T, Kanai K, Kako M, et al. Interferon-α2a for chronic hepatitis B with e antigen or antibody: Comparable antiviral effects on wild-type virus and precore mutant. J Viral Hepatitis 1995;2:243-50.
21. Gunther S, Meisel H, Reip A, et al. Frequent and rapid emergence of mutated pre-C sequences in HBV from e-antigen positive carriers who seroconvert to anti-HBe during interferon treatment. Virology 1992; 187:271-9.
22. Pollack JR, Ganem DA. RNA stem-loop structure directs hepatitis B virus genomic RNA encapsidation. J Virol 1993;67:3254-63.
23. Myers RM, Tilly K, Maniatis T. Fine structure genetic analysis of a beta-globin promoter. Science 1986;232:613-8.
24. Akahane Y, Yamanaka T, Suzuki H, et al. Chronic active hepatitis with hepatitis B virus DNA and antibody against e antigen in the serum. Disturbed synthesis and secretion of e antigen from hepatocytes due to a point mutation in the precore region. Gastroenterology 1990;99: 1113-9.
25. 1764) of hepatitis B virus: Clinical significance and an easy method for detection. J Gen Virol 1995;76:3159-64.
26. Marcellin P, Martinot PM, Loriot MA, et al. Persistence of hepatitis B virus DNA demonstrated by polymerase chain reaction in serum and liver after loss of HBsAg induced by antiviral therapy. Ann Intern Med 1990;112:227-8.
27. Carman WF, Dourakis S, Karayiannis P, et al. Incidence of hepatitis B viraemia, detected using the polymerase chain reaction, after successful therapy of hepatitis B virus carriers with interferon-alpha. J Med Virol 1991;34:114-8.
28. Molina J, Bartolome J, Moraleda G, et al. Persistence of hepatitis B virus DNA after reduction of viral replication in serum and liver. J Med Virol 1992;38:11-5.